Goa state warns Abbott India on antacid license suspension streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The U.S. based drugmaker is locked in a tussle with drug regulators in the tourist state of Goa in western India after the company, starting August, voluntarily recalled many batches of its Digene Gel syrup produced there after it received customer complaints on taste and odor. Abbott says there is no impact on patient health.
By Rishika Sadam HYDERABAD, India (Reuters) - India s Goa state has warned the local unit of Abbott Laboratories it plans to suspend the manufacturing .
India's Goa state has warned the local unit of Abbott Laboratories it plans to suspend the manufacturing licence of its antacid medicine after inspectors flagged contamination risks and sanitization issues at its factory, government documents show. The U.S. based drugmaker is locked in a tussle with drug regulators in the tourist state of Goa in western India after the company, starting in August, voluntarily recalled many batches of its Digene Gel syrup produced there after it received customer complaints on taste and odor. Abbott says there is no impact on patient health.
Govt committed to enhance water infrastructure: Shirodkar navhindtimes.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from navhindtimes.in Daily Mail and Mail on Sunday newspapers.